Parallel study as pilot for long half life drug [Design Issues]

posted by Dr_Dan  – Germany, 2012-05-07 18:00 (5167 d 20:33 ago) – Posting: # 8525
Views: 5,855

Dear John
running a pilot parallel study does not necessarily mean that you have to conduct your pivotal studies also as parallel studies. But considering the long half life of the drug it is IMHO not reasonable to conduct a cross-over study. The CV% you get from the pilot is the total CV%, right. You use this to calculate your sample size for the pivotal study but it does not predetermine the design of the pivotal study.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
236 visitors (0 registered, 236 guests [including 19 identified bots]).
Forum time: 14:34 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5